| Entry |
|
|---|
| Name |
Pridopidine (USAN/INN) |
|---|
| Formula |
C15H23NO2S
|
|---|
| Exact mass |
281.1450
|
|---|
| Mol weight |
281.42
|
|---|
| Structure |
|
|---|
| Simcomp |
|
|---|
| Remark |
|
|---|
| Efficacy |
Antipsychotic, Antiparkinsonian |
|---|
| Comment |
Treatment of schizophrenia, Parkinson's disease and Huntington's disease
|
|---|
| Target |
|
|---|
| Pathway |
| hsa04080 | Neuroactive ligand-receptor interaction |
|
|---|
| Brite |
Target-based classification of drugs [BR:br08310]
G Protein-coupled receptors
Rhodopsin family
Dopamine
DRD2
D09953 Pridopidine (USAN/INN)
|
|---|
| Other DBs |
|
|---|
| LinkDB |
|
|---|
| KCF data |
ATOM 19
1 C1x C 16.1700 -24.9200
2 N1y N 16.1700 -26.3200
3 C1x C 17.3824 -27.0200
4 C1x C 18.5949 -26.3200
5 C1y C 18.5949 -24.9200
6 C1x C 17.3824 -24.2200
7 C8y C 19.8260 -24.2090
8 C8x C 21.0312 -24.9047
9 C8x C 22.2435 -24.2046
10 C8x C 22.2435 -22.8046
11 C8y C 21.0383 -22.1089
12 C8x C 19.8259 -22.8090
13 C1b C 14.9576 -27.0200
14 C1b C 13.7621 -26.3296
15 C1a C 12.5747 -27.0151
16 S4a S 21.0385 -20.7204
17 C1a C 21.0385 -19.3204
18 O3c O 22.4385 -20.7204
19 O3c O 19.6385 -20.7204
BOND 20
1 1 2 1
2 2 3 1
3 3 4 1
4 4 5 1
5 5 6 1
6 1 6 1
7 5 7 1
8 7 8 1
9 8 9 2
10 9 10 1
11 10 11 2
12 11 12 1
13 7 12 2
14 2 13 1
15 13 14 1
16 14 15 1
17 11 16 1
18 16 17 1
19 16 18 2
20 16 19 2
|
|---|
